Financhill
Sell
48

NKE Quote, Financials, Valuation and Earnings

Last price:
$63.07
Seasonality move :
3.43%
Day range:
$61.92 - $64.20
52-week range:
$52.28 - $82.44
Dividend yield:
2.53%
P/E ratio:
37.36x
P/S ratio:
2.02x
P/B ratio:
6.69x
Volume:
35.5M
Avg. volume:
20.1M
1-year change:
-15.81%
Market cap:
$94.2B
Revenue:
$46.4B
EPS (TTM):
$1.71
Period Ending 2021-05-31 2022-05-31 2023-05-31 2024-05-31 2025-05-31
Revenue $44.5B $46.8B $51.2B $51.4B $46.4B
Revenue Growth (YoY) 18.9% 5.17% 9.4% 0.38% -9.7%
 
Cost of Revenues $24.6B $25.2B $29.5B $28.8B $26.8B
Gross Profit $19.9B $21.6B $21.7B $22.6B $19.6B
Gross Profit Margin 44.74% 46.13% 42.36% 44.01% 42.21%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $13B $14.8B $16.4B $16.6B $16.1B
Other Inc / (Exp) -$14M $181M $280M $228M $76M
Operating Expenses $12.8B $14.8B $16.4B $16.6B $16.1B
Operating Income $7.1B $6.8B $5.3B $6B $3.5B
 
Net Interest Expenses $289M $292M $283M $261M $289M
EBT. Incl. Unusual Items $6.7B $6.7B $6.2B $6.7B $3.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $934M $605M $1.1B $1B $666M
Net Income to Company $5.7B $6B $5.1B $5.7B $3.2B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.7B $6B $5.1B $5.7B $3.2B
 
Basic EPS (Cont. Ops) $3.64 $3.83 $3.27 $3.76 $2.17
Diluted EPS (Cont. Ops) $3.56 $3.75 $3.23 $3.73 $2.16
Weighted Average Basic Share $1.6B $1.6B $1.6B $1.5B $1.5B
Weighted Average Diluted Share $1.6B $1.6B $1.6B $1.5B $1.5B
 
EBITDA $7.9B $7.5B $6B $6.8B $4.3B
EBIT $7.1B $6.8B $5.3B $6B $3.5B
 
Revenue (Reported) $44.5B $46.8B $51.2B $51.4B $46.4B
Operating Income (Reported) $7.1B $6.8B $5.3B $6B $3.5B
Operating Income (Adjusted) $7.1B $6.8B $5.3B $6B $3.5B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $11.4B $13.3B $13.4B $12.4B $12.4B
Revenue Growth (YoY) 1.43% 17% 0.56% -7.53% 0.37%
 
Cost of Revenues $6.1B $7.8B $7.5B $7B $7.4B
Gross Profit $5.3B $5.5B $5.9B $5.4B $5B
Gross Profit Margin 46.26% 41.58% 44.11% 43.33% 40.58%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.8B $4.1B $4.1B $4B $4B
Other Inc / (Exp) $102M $79M $75M $8M --
Operating Expenses $3.8B $4.1B $4.1B $4B $4B
Operating Income $1.5B $1.4B $1.8B $1.4B $1B
 
Net Interest Expenses $72M $63M $68M $71M $52M
EBT. Incl. Unusual Items $1.5B $1.7B $1.9B $1.4B $999M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $164M $319M $344M $253M $207M
Net Income to Company $1.3B $1.3B $1.6B $1.2B $792M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.3B $1.3B $1.6B $1.2B $792M
 
Basic EPS (Cont. Ops) $0.84 $0.85 $1.04 $0.78 $0.54
Diluted EPS (Cont. Ops) $0.83 $0.85 $1.03 $0.78 $0.53
Weighted Average Basic Share $1.6B $1.6B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.6B $1.6B $1.5B $1.5B $1.5B
 
EBITDA $1.7B $1.6B $1.9B $1.5B $1.2B
EBIT $1.5B $1.4B $1.8B $1.4B $1B
 
Revenue (Reported) $11.4B $13.3B $13.4B $12.4B $12.4B
Operating Income (Reported) $1.5B $1.4B $1.8B $1.4B $1B
Operating Income (Adjusted) $1.5B $1.4B $1.8B $1.4B $1B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $46.3B $49.2B $51.5B $49.1B $46.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $24.8B $27.6B $29.3B $27.4B $27.6B
Gross Profit $21.5B $21.6B $22.2B $21.7B $19B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.1B $15.5B $16.6B $16.4B $16.1B
Other Inc / (Exp) $167M $265M $140M $206M --
Operating Expenses $14.1B $15.5B $16.6B $16.4B $16.1B
Operating Income $7.4B $6.1B $5.6B $5.3B $2.9B
 
Net Interest Expenses $290M $287M $276M $276M $258M
EBT. Incl. Unusual Items $7.1B $6.5B $6.3B $5.9B $3.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $928M $888M $994M $967M $559M
Net Income to Company $6.2B $5.6B $5.3B $4.9B $2.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.2B $5.6B $5.3B $4.9B $2.5B
 
Basic EPS (Cont. Ops) $3.90 $3.59 $3.46 $3.25 $1.71
Diluted EPS (Cont. Ops) $3.81 $3.54 $3.42 $3.24 $1.71
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $8.2B $6.8B $6.3B $6.1B $3.6B
EBIT $7.4B $6.1B $5.6B $5.3B $2.9B
 
Revenue (Reported) $46.3B $49.2B $51.5B $49.1B $46.6B
Operating Income (Reported) $7.4B $6.1B $5.6B $5.3B $2.9B
Operating Income (Adjusted) $7.4B $6.1B $5.6B $5.3B $2.9B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $23.6B $26B $26.3B $24B $24.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.6B $15B $14.8B $13.4B $14.2B
Gross Profit $11B $11B $11.5B $10.6B $9.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.3B $8B $8.3B $8.1B $8.1B
Other Inc / (Exp) $141M $225M $85M $63M --
Operating Expenses $7.3B $8B $8.3B $8.1B $8.1B
Operating Income $3.7B $3B $3.3B $2.5B $1.9B
 
Net Interest Expenses $146M $139M $131M $146M $115M
EBT. Incl. Unusual Items $3.6B $3.5B $3.6B $2.7B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $396M $679M $542M $509M $402M
Net Income to Company $3.2B $2.8B $3B $2.2B $1.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.2B $2.8B $3B $2.2B $1.5B
 
Basic EPS (Cont. Ops) $2.03 $1.79 $1.99 $1.48 $1.03
Diluted EPS (Cont. Ops) $1.98 $1.77 $1.97 $1.48 $1.03
Weighted Average Basic Share $3.2B $3.1B $3B $3B $3B
Weighted Average Diluted Share $3.2B $3.2B $3.1B $3B $3B
 
EBITDA $4.1B $3.3B $3.7B $2.9B $2.3B
EBIT $3.7B $3B $3.3B $2.5B $1.9B
 
Revenue (Reported) $23.6B $26B $26.3B $24B $24.2B
Operating Income (Reported) $3.7B $3B $3.3B $2.5B $1.9B
Operating Income (Adjusted) $3.7B $3B $3.3B $2.5B $1.9B
Period Ending 2021-05-31 2022-05-31 2023-05-31 2024-05-31 2025-05-31
Cash and Equivalents $13.5B $13B $10.7B $11.6B $9.2B
Short Term Investments $3.6B $4.4B $3.2B $1.7B $1.7B
Accounts Receivable, Net $4.5B $4.7B $4.1B $4.4B $4.7B
Inventory $6.9B $8.4B $8.5B $7.5B $7.5B
Prepaid Expenses $338M $329M $372M $420M $498M
Other Current Assets $1.5B $2.1B $1.9B $1.9B $2B
Total Current Assets $26.3B $28.2B $25.2B $25.4B $23.4B
 
Property Plant And Equipment $8B $7.7B $8B $7.7B $7.5B
Long-Term Investments $16M $206M $64M $44M $46M
Goodwill $242M $284M $281M $240M $240M
Other Intangibles $269M $286M $274M $259M $259M
Other Long-Term Assets $2.9B $3.8B $3.8B $4.5B $5.2B
Total Assets $37.7B $40.3B $37.5B $38.1B $36.6B
 
Accounts Payable $2.8B $3.4B $2.9B $2.9B $3.5B
Accrued Expenses $3.2B $2.5B $1.9B $2B $1.8B
Current Portion Of Long-Term Debt -- $500M -- $1B --
Current Portion Of Capital Lease Obligations $467M $420M $425M $477M $502M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $9.7B $10.7B $9.3B $10.6B $10.6B
 
Long-Term Debt $12.3B $11.7B $11.7B $10.5B $10.5B
Capital Leases -- -- -- -- --
Total Liabilities $25B $25B $23.5B $23.7B $23.4B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj -$380M $318M $231M $53M -$258M
Common Equity $12.8B $15.3B $14B $14.4B $13.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $12.8B $15.3B $14B $14.4B $13.2B
 
Total Liabilities and Equity $37.7B $40.3B $37.5B $38.1B $36.6B
Cash and Short Terms $13.5B $13B $10.7B $11.6B $9.2B
Total Debt $12.3B $12.2B $11.7B $11.5B $10.5B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Cash and Equivalents $15.1B $10.6B $9.9B $9.8B $8.3B
Short Term Investments $4.4B $4.1B $2B $1.8B --
Accounts Receivable, Net $3.7B $5.4B $4.8B $5.3B $5.7B
Inventory $6.5B $9.3B $8B $8B $7.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.8B $2.1B $1.9B $1.9B --
Total Current Assets $27.2B $27.4B $24.6B $25B $24B
 
Property Plant And Equipment $7.8B $7.7B $8.1B $7.6B $7.7B
Long-Term Investments $102M $194M $49M $159M $122M
Goodwill $242M $281M $281M $240M --
Other Intangibles $265M $280M $269M $259M --
Other Long-Term Assets $3.4B $4B $3.9B $4.9B --
Total Assets $38.9B $39.6B $37.2B $38B $37.8B
 
Accounts Payable $2.8B $2.8B $2.7B $3.3B $3.7B
Accrued Expenses $2.5B $3.1B $1.6B $2B --
Current Portion Of Long-Term Debt -- $500M -- $1B --
Current Portion Of Capital Lease Obligations $462M $426M $456M $481M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $8.9B $10.2B $9B $11.2B $11.6B
 
Long-Term Debt $12.3B $11.6B $11.7B $10.5B $9.8B
Capital Leases -- -- -- -- --
Total Liabilities $24B $24.4B $23.1B $23.9B $23.7B
 
Common Stock $3M $3M $3M $3M $3M
Other Common Equity Adj $145M $559M $121M $202M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $14.9B $15.3B $14.1B $14B $14.1B
 
Total Liabilities and Equity $38.9B $39.6B $37.2B $38B $37.8B
Cash and Short Terms $15.1B $10.6B $9.9B $9.8B $8.3B
Total Debt $12.3B $12.1B $11.7B $11.5B $10.8B
Period Ending 2021-05-31 2022-05-31 2023-05-31 2024-05-31 2025-05-31
Net Income to Stockholders $5.7B $6B $5.1B $5.7B $3.2B
Depreciation & Amoritzation $744M $717M $703M $796M $775M
Stock-Based Compensation $611M $638M $755M $804M $709M
Change in Accounts Receivable -$1.6B -$504M $489M -$329M -$257M
Change in Inventories $507M -$1.7B -$133M $908M $120M
Cash From Operations $6.7B $5.2B $5.8B $7.4B $3.7B
 
Capital Expenditures $695M $758M $969M $812M $430M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.8B -$1.5B $564M $894M -$275M
 
Dividends Paid (Ex Special Dividend) $1.6B $1.8B $2B $2.2B $2.3B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$197M -- -$500M -- -$1B
Repurchase of Common Stock $608M $4B $5.5B $4.3B $3B
Other Financing Activities -$136M -$151M -$102M -$136M -$85M
Cash From Financing -$1.5B -$4.8B -$7.4B -$5.9B -$5.8B
 
Beginning Cash (CF) $9.9B $8.6B $7.4B $9.9B $7.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.5B -$1.3B -$1.1B $2.4B -$2.4B
Ending Cash (CF) $11.6B $7.1B $6.2B $12.3B $5.1B
 
Levered Free Cash Flow $6B $4.4B $4.9B $6.6B $3.3B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $1.3B $1.3B $1.6B $1.2B $792M
Depreciation & Amoritzation $181M $173M $191M $190M $179M
Stock-Based Compensation $170M $194M $206M $192M $176M
Change in Accounts Receivable $507M -$463M -$28M -$631M -$806M
Change in Inventories $167M $415M $756M $132M $353M
Cash From Operations $2.8B $1B $2.8B $1B $579M
 
Capital Expenditures $178M $236M $205M $129M $193M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.6B $191M $457M -$74M -$49M
 
Dividends Paid (Ex Special Dividend) $438M $480M $523M $557M $598M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock $971M $1.6B $1.2B $1.1B $20M
Other Financing Activities -$67M -$46M -$59M -$46M --
Cash From Financing -$1.1B -$1.9B -$1.6B -$1.4B -$579M
 
Beginning Cash (CF) $10.8B $6.5B $7.9B $8B $7B
Foreign Exchange Rate Adjustment -$17M -$11M $19M -$33M -$1M
Additions / Reductions $31M -$736M $1.7B -$506M -$50M
Ending Cash (CF) $10.8B $5.7B $9.7B $7.4B $6.9B
 
Levered Free Cash Flow $2.6B $765M $2.6B $920M $386M
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $6.2B $5.6B $5.3B $4.9B $2.5B
Depreciation & Amoritzation $741M $701M $743M $792M $766M
Stock-Based Compensation $592M $696M $793M $777M $695M
Change in Accounts Receivable -$142M -$1.9B $718M -$623M -$335M
Change in Inventories -$546M -$2.9B $1.3B -$132M $410M
Cash From Operations $7.2B $2.7B $7.2B $6.1B $3.1B
 
Capital Expenditures $713M $896M $927M $603M $581M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2B -$442M $1.5B -$221M -$143M
 
Dividends Paid (Ex Special Dividend) $1.7B $1.9B $2.1B $2.2B $2.4B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock $2.3B $4.8B $5.3B $4.2B $851M
Other Financing Activities -$151M -$110M -$134M -$99M --
Cash From Financing -$3B -$6.3B -$7.3B -$5.8B -$3.9B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.1B -$4.3B $1.4B $60M -$1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.5B $1.8B $6.3B $5.5B $2.5B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $3.2B $2.8B $3B $2.2B $1.5B
Depreciation & Amoritzation $358M $342M $382M $378M $369M
Stock-Based Compensation $306M $364M $402M $375M $361M
Change in Accounts Receivable $543M -$878M -$649M -$943M -$1B
Change in Inventories $268M -$948M $493M -$547M -$257M
Cash From Operations $3.9B $1.4B $2.8B $1.4B $801M
 
Capital Expenditures $362M $500M $458M $249M $400M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1B -$23M $875M -$240M -$108M
 
Dividends Paid (Ex Special Dividend) $873M $960M $1B $1.1B $1.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock $1.7B $2.6B $2.3B $2.3B $146M
Other Financing Activities -$109M -$68M -$100M -$63M --
Cash From Financing -$1.8B -$3.3B -$3.2B -$3.1B -$1.2B
 
Beginning Cash (CF) $21.5B $13.7B $14.1B $16.5B $14B
Foreign Exchange Rate Adjustment -$55M -$98M $3M -$14M -$6M
Additions / Reductions $862M -$2.1B $478M -$1.9B -$490M
Ending Cash (CF) $22.3B $11.5B $14.6B $14.6B $13.5B
 
Levered Free Cash Flow $3.5B $858M $2.3B $1.2B $401M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.75% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.49% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.95% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock